# Greater Baltimore Medical Center – FDA Inspection, Jun 15, 2012

Source: https://www.keypedia.com/records/fda_inspections/greater-baltimore-medical-center/429db247-3932-41c5-85e9-f83ff23b9fc7
Source feed: FDA_Inspections

> FDA inspection 786212 of Greater Baltimore Medical Center, June 15, 2012. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 211 and 606. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 786212
- Company Name: Greater Baltimore Medical Center
- Inspection Date: 2012-06-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1305080 - 2026-02-05
- [FDA Inspection 1221203 - 2023-10-26](https://www.keypedia.com/records/fda_inspections/greater-baltimore-medical-center/a35a99c8-91a0-4a86-a3ca-a4f20aa62689)
- FDA Inspection 1121801 - 2019-11-01
- FDA Inspection 1038518 - 2017-12-08
- FDA Inspection 982274 - 2016-07-14

Company: https://www.keypedia.com/companies/greater-baltimore-medical-center/252bbb07-3732-43c3-a3ee-eccd341f8dc9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
